Global and United States AT1 Receptor Antagonists Market Insights, Forecast to 2026

Global and United States AT1 Receptor Antagonists Market Insights, Forecast to 2026

Nov 2020 QYResearch Pharmaceutical147 Pages Price :
$ 3900
AT1 Receptor Antagonists market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global AT1 Receptor Antagonists market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Segment by Type, the AT1 Receptor Antagonists market is segmented into
Valsartan
Telmisartan
Losartan
Irbesartan
Azilsartan
Olmesartan

Segment by Application, the AT1 Receptor Antagonists market is segmented into
Hypertension
Cardiovascular Diseases
Kidney Diseases
Other

Regional and Country-level Analysis
The AT1 Receptor Antagonists market is analysed and market size information is provided by regions (countries).
The key regions covered in the AT1 Receptor Antagonists market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and AT1 Receptor Antagonists Market Share Analysis
AT1 Receptor Antagonists market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in AT1 Receptor Antagonists business, the date to enter into the AT1 Receptor Antagonists market, AT1 Receptor Antagonists product introduction, recent developments, etc.
The major vendors covered:
Pfizer
Novartis
Merck
Astra Zeneca
Jhonson and Johnson
Eli Lilly
Sanofi
Bristol-Myers Squibb
Bayer
GSK
Teva Pharmaceutical
1 Study Coverage
1.1 AT1 Receptor Antagonists Product Introduction
1.2 Market Segments
1.3 Key AT1 Receptor Antagonists Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global AT1 Receptor Antagonists Market Size Growth Rate by Type
1.4.2 Valsartan
1.4.3 Telmisartan
1.4.4 Losartan
1.4.5 Irbesartan
1.4.6 Azilsartan
1.4.7 Olmesartan
1.5 Market by Application
1.5.1 Global AT1 Receptor Antagonists Market Size Growth Rate by Application
1.5.2 Hypertension
1.5.3 Cardiovascular Diseases
1.5.4 Kidney Diseases
1.5.5 Other
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global AT1 Receptor Antagonists Market Size, Estimates and Forecasts
2.1.1 Global AT1 Receptor Antagonists Revenue 2015-2026
2.1.2 Global AT1 Receptor Antagonists Sales 2015-2026
2.2 Global AT1 Receptor Antagonists, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 AT1 Receptor Antagonists Historical Market Size by Region (2015-2020)
2.3.1 Global AT1 Receptor Antagonists Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global AT1 Receptor Antagonists Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 AT1 Receptor Antagonists Market Estimates and Projections by Region (2021-2026)
2.4.1 Global AT1 Receptor Antagonists Sales Forecast by Region (2021-2026)
2.4.2 Global AT1 Receptor Antagonists Revenue Forecast by Region (2021-2026)

3 Global AT1 Receptor Antagonists Competitor Landscape by Players
3.1 Global Top AT1 Receptor Antagonists Sales by Manufacturers
3.1.1 Global AT1 Receptor Antagonists Sales by Manufacturers (2015-2020)
3.1.2 Global AT1 Receptor Antagonists Sales Market Share by Manufacturers (2015-2020)
3.2 Global AT1 Receptor Antagonists Manufacturers by Revenue
3.2.1 Global AT1 Receptor Antagonists Revenue by Manufacturers (2015-2020)
3.2.2 Global AT1 Receptor Antagonists Revenue Share by Manufacturers (2015-2020)
3.2.3 Global AT1 Receptor Antagonists Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by AT1 Receptor Antagonists Revenue in 2019
3.2.5 Global AT1 Receptor Antagonists Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global AT1 Receptor Antagonists Price by Manufacturers
3.4 Global AT1 Receptor Antagonists Manufacturing Base Distribution, Product Types
3.4.1 AT1 Receptor Antagonists Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers AT1 Receptor Antagonists Product Type
3.4.3 Date of International Manufacturers Enter into AT1 Receptor Antagonists Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global AT1 Receptor Antagonists Market Size by Type (2015-2020)
4.1.1 Global AT1 Receptor Antagonists Sales by Type (2015-2020)
4.1.2 Global AT1 Receptor Antagonists Revenue by Type (2015-2020)
4.1.3 AT1 Receptor Antagonists Average Selling Price (ASP) by Type (2015-2026)
4.2 Global AT1 Receptor Antagonists Market Size Forecast by Type (2021-2026)
4.2.1 Global AT1 Receptor Antagonists Sales Forecast by Type (2021-2026)
4.2.2 Global AT1 Receptor Antagonists Revenue Forecast by Type (2021-2026)
4.2.3 AT1 Receptor Antagonists Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global AT1 Receptor Antagonists Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global AT1 Receptor Antagonists Market Size by Application (2015-2020)
5.1.1 Global AT1 Receptor Antagonists Sales by Application (2015-2020)
5.1.2 Global AT1 Receptor Antagonists Revenue by Application (2015-2020)
5.1.3 AT1 Receptor Antagonists Price by Application (2015-2020)
5.2 AT1 Receptor Antagonists Market Size Forecast by Application (2021-2026)
5.2.1 Global AT1 Receptor Antagonists Sales Forecast by Application (2021-2026)
5.2.2 Global AT1 Receptor Antagonists Revenue Forecast by Application (2021-2026)
5.2.3 Global AT1 Receptor Antagonists Price Forecast by Application (2021-2026)

6 United States by Players, Type and Application
6.1 United States AT1 Receptor Antagonists Market Size YoY Growth 2015-2026
6.1.1 United States AT1 Receptor Antagonists Sales YoY Growth 2015-2026
6.1.2 United States AT1 Receptor Antagonists Revenue YoY Growth 2015-2026
6.1.3 United States AT1 Receptor Antagonists Market Share in Global Market 2015-2026
6.2 United States AT1 Receptor Antagonists Market Size by Players (International and Local Players)
6.2.1 United States Top AT1 Receptor Antagonists Players by Sales (2015-2020)
6.2.2 United States Top AT1 Receptor Antagonists Players by Revenue (2015-2020)
6.3 United States AT1 Receptor Antagonists Historic Market Review by Type (2015-2020)
6.3.1 United States AT1 Receptor Antagonists Sales Market Share by Type (2015-2020)
6.3.2 United States AT1 Receptor Antagonists Revenue Market Share by Type (2015-2020)
6.3.3 United States AT1 Receptor Antagonists Price by Type (2015-2020)
6.4 United States AT1 Receptor Antagonists Market Estimates and Forecasts by Type (2021-2026)
6.4.1 United States AT1 Receptor Antagonists Sales Forecast by Type (2021-2026)
6.4.2 United States AT1 Receptor Antagonists Revenue Forecast by Type (2021-2026)
6.4.3 United States AT1 Receptor Antagonists Price Forecast by Type (2021-2026)
6.5 United States AT1 Receptor Antagonists Historic Market Review by Application (2015-2020)
6.5.1 United States AT1 Receptor Antagonists Sales Market Share by Application (2015-2020)
6.5.2 United States AT1 Receptor Antagonists Revenue Market Share by Application (2015-2020)
6.5.3 United States AT1 Receptor Antagonists Price by Application (2015-2020)
6.6 United States AT1 Receptor Antagonists Market Estimates and Forecasts by Application (2021-2026)
6.6.1 United States AT1 Receptor Antagonists Sales Forecast by Application (2021-2026)
6.6.2 United States AT1 Receptor Antagonists Revenue Forecast by Application (2021-2026)
6.6.3 United States AT1 Receptor Antagonists Price Forecast by Application (2021-2026)

7 North America
7.1 North America AT1 Receptor Antagonists Market Size YoY Growth 2015-2026
7.2 North America AT1 Receptor Antagonists Market Facts & Figures by Country
7.2.1 North America AT1 Receptor Antagonists Sales by Country (2015-2020)
7.2.2 North America AT1 Receptor Antagonists Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada

8 Europe
8.1 Europe AT1 Receptor Antagonists Market Size YoY Growth 2015-2026
8.2 Europe AT1 Receptor Antagonists Market Facts & Figures by Country
8.2.1 Europe AT1 Receptor Antagonists Sales by Country
8.2.2 Europe AT1 Receptor Antagonists Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia

9 Asia Pacific
9.1 Asia Pacific AT1 Receptor Antagonists Market Size YoY Growth 2015-2026
9.2 Asia Pacific AT1 Receptor Antagonists Market Facts & Figures by Country
9.2.1 Asia Pacific AT1 Receptor Antagonists Sales by Region (2015-2020)
9.2.2 Asia Pacific AT1 Receptor Antagonists Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam

10 Latin America
10.1 Latin America AT1 Receptor Antagonists Market Size YoY Growth 2015-2026
10.2 Latin America AT1 Receptor Antagonists Market Facts & Figures by Country
10.2.1 Latin America AT1 Receptor Antagonists Sales by Country
10.2.2 Latin America AT1 Receptor Antagonists Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina

11 Middle East and Africa
11.1 Middle East and Africa AT1 Receptor Antagonists Market Size YoY Growth 2015-2026
11.2 Middle East and Africa AT1 Receptor Antagonists Market Facts & Figures by Country
11.2.1 Middle East and Africa AT1 Receptor Antagonists Sales by Country
11.2.2 Middle East and Africa AT1 Receptor Antagonists Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E

12 Company Profiles
12.1 Pfizer
12.1.1 Pfizer Corporation Information
12.1.2 Pfizer Description and Business Overview
12.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Pfizer AT1 Receptor Antagonists Products Offered
12.1.5 Pfizer Recent Development
12.2 Novartis
12.2.1 Novartis Corporation Information
12.2.2 Novartis Description and Business Overview
12.2.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Novartis AT1 Receptor Antagonists Products Offered
12.2.5 Novartis Recent Development
12.3 Merck
12.3.1 Merck Corporation Information
12.3.2 Merck Description and Business Overview
12.3.3 Merck Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Merck AT1 Receptor Antagonists Products Offered
12.3.5 Merck Recent Development
12.4 Astra Zeneca
12.4.1 Astra Zeneca Corporation Information
12.4.2 Astra Zeneca Description and Business Overview
12.4.3 Astra Zeneca Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Astra Zeneca AT1 Receptor Antagonists Products Offered
12.4.5 Astra Zeneca Recent Development
12.5 Jhonson and Johnson
12.5.1 Jhonson and Johnson Corporation Information
12.5.2 Jhonson and Johnson Description and Business Overview
12.5.3 Jhonson and Johnson Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Jhonson and Johnson AT1 Receptor Antagonists Products Offered
12.5.5 Jhonson and Johnson Recent Development
12.6 Eli Lilly
12.6.1 Eli Lilly Corporation Information
12.6.2 Eli Lilly Description and Business Overview
12.6.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Eli Lilly AT1 Receptor Antagonists Products Offered
12.6.5 Eli Lilly Recent Development
12.7 Sanofi
12.7.1 Sanofi Corporation Information
12.7.2 Sanofi Description and Business Overview
12.7.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Sanofi AT1 Receptor Antagonists Products Offered
12.7.5 Sanofi Recent Development
12.8 Bristol-Myers Squibb
12.8.1 Bristol-Myers Squibb Corporation Information
12.8.2 Bristol-Myers Squibb Description and Business Overview
12.8.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Bristol-Myers Squibb AT1 Receptor Antagonists Products Offered
12.8.5 Bristol-Myers Squibb Recent Development
12.9 Bayer
12.9.1 Bayer Corporation Information
12.9.2 Bayer Description and Business Overview
12.9.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Bayer AT1 Receptor Antagonists Products Offered
12.9.5 Bayer Recent Development
12.10 GSK
12.10.1 GSK Corporation Information
12.10.2 GSK Description and Business Overview
12.10.3 GSK Sales, Revenue and Gross Margin (2015-2020)
12.10.4 GSK AT1 Receptor Antagonists Products Offered
12.10.5 GSK Recent Development
12.11 Pfizer
12.11.1 Pfizer Corporation Information
12.11.2 Pfizer Description and Business Overview
12.11.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Pfizer AT1 Receptor Antagonists Products Offered
12.11.5 Pfizer Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porters Five Forces Analysis
13.5 Primary Interviews with Key AT1 Receptor Antagonists Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 AT1 Receptor Antagonists Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Table

List of Tables
Table 1. AT1 Receptor Antagonists Market Segments
Table 2. Ranking of Global Top AT1 Receptor Antagonists Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global AT1 Receptor Antagonists Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Valsartan
Table 5. Major Manufacturers of Telmisartan
Table 6. Major Manufacturers of Losartan
Table 7. Major Manufacturers of Irbesartan
Table 8. Major Manufacturers of Azilsartan
Table 9. Major Manufacturers of Olmesartan
Table 10. Global AT1 Receptor Antagonists Market Size Growth Rate by Application 2020-2026 (K Units)
Table 11. Global AT1 Receptor Antagonists Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 12. Global AT1 Receptor Antagonists Sales by Regions 2015-2020 (K Units)
Table 13. Global AT1 Receptor Antagonists Sales Market Share by Regions (2015-2020)
Table 14. Global AT1 Receptor Antagonists Revenue by Regions 2015-2020 (US$ Million)
Table 15. Global AT1 Receptor Antagonists Sales Forecast by Region (2021-2026) (K Units)
Table 16. Global AT1 Receptor Antagonists Sales by Manufacturers (2015-2020) (K Units)
Table 17. Global AT1 Receptor Antagonists Sales Share by Manufacturers (2015-2020)
Table 18. Global AT1 Receptor Antagonists Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global AT1 Receptor Antagonists by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in AT1 Receptor Antagonists as of 2019)
Table 20. AT1 Receptor Antagonists Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. AT1 Receptor Antagonists Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers AT1 Receptor Antagonists Price (2015-2020) (USD/Unit)
Table 23. AT1 Receptor Antagonists Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers AT1 Receptor Antagonists Product Type
Table 25. Date of International Manufacturers Enter into AT1 Receptor Antagonists Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global AT1 Receptor Antagonists Sales by Type (2015-2020) (K Units)
Table 28. Global AT1 Receptor Antagonists Sales Share by Type (2015-2020)
Table 29. Global AT1 Receptor Antagonists Revenue by Type (2015-2020) (US$ Million)
Table 30. Global AT1 Receptor Antagonists Revenue Share by Type (2015-2020)
Table 31. AT1 Receptor Antagonists Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 32. Global AT1 Receptor Antagonists Sales Share by Type (2021-2026)
Table 33. Global AT1 Receptor Antagonists Sales by Application (2015-2020) (K Units)
Table 34. Global AT1 Receptor Antagonists Sales Share by Application (2015-2020)
Table 35. Global AT1 Receptor Antagonists Sales Share by Application (2021-2026)
Table 36. Global AT1 Receptor Antagonists Sales Market Share Forecast by Application (2021-2026)
Table 37. Global AT1 Receptor Antagonists Revenue by Application (2015-2020) (US$ Million)
Table 38. Global AT1 Receptor Antagonists Revenue Market Share Forecast by Application (2021-2026)
Table 39. United States AT1 Receptor Antagonists Sales (K Units) of Key Companies (2015-2020)
Table 40. United States AT1 Receptor Antagonists Sales Share by Company (2015-2020)
Table 41. United States AT1 Receptor Antagonists Revenue (US$ Million) by Company (2015-2020)
Table 42. United States AT1 Receptor Antagonists Sales (K Units) by Type (2015-2020)
Table 43. United States AT1 Receptor Antagonists Sales Share by Type (2015-2020)
Table 44. United States AT1 Receptor Antagonists Revenue (US$ Million) Market Share by Type (2015-2020)
Table 45. United States AT1 Receptor Antagonists Price (K Units) by Type (2015-2020)
Table 46. United States AT1 Receptor Antagonists Sales (K Units) by Type (2021-2026)
Table 47. United States AT1 Receptor Antagonists Sales Share by Type (2021-2026)
Table 48. United States AT1 Receptor Antagonists Revenue (US$ Million) Market Share by Type (2021-2026)
Table 49. United States AT1 Receptor Antagonists Revenue Share by Type (2021-2026)
Table 50. United States AT1 Receptor Antagonists Price (K Units) by Type (2021-2026)
Table 51. United States AT1 Receptor Antagonists Sales (K Units) by Application (2015-2020)
Table 52. United States AT1 Receptor Antagonists Sales Share by Application (2015-2020)
Table 53. United States AT1 Receptor Antagonists Revenue (US$ Million) Market Share by Application (2015-2020)
Table 54. United States AT1 Receptor Antagonists Sales (K Units) by Application (2021-2026)
Table 55. United States AT1 Receptor Antagonists Sales Share by Application (2021-2026)
Table 56. United States AT1 Receptor Antagonists Revenue (US$ Million) Market Share by Application (2021-2026)
Table 57. United States AT1 Receptor Antagonists Revenue Share by Application (2021-2026)
Table 58. North America AT1 Receptor Antagonists Sales by Country (2015-2020) (K Units)
Table 59. North America AT1 Receptor Antagonists Sales Market Share by Country (2015-2020)
Table 60. North America AT1 Receptor Antagonists Revenue by Country (2015-2020) (US$ Million)
Table 61. North America AT1 Receptor Antagonists Revenue Market Share by Country (2015-2020)
Table 62. Europe AT1 Receptor Antagonists Sales by Country (2015-2020) (K Units)
Table 63. Europe AT1 Receptor Antagonists Sales Market Share by Country (2015-2020)
Table 64. Europe AT1 Receptor Antagonists Revenue by Country (2015-2020) (US$ Million)
Table 65. Europe AT1 Receptor Antagonists Revenue Market Share by Country (2015-2020)
Table 66. Asia Pacific AT1 Receptor Antagonists Sales by Region (2015-2020) (K Units)
Table 67. Asia Pacific AT1 Receptor Antagonists Sales Market Share by Region (2015-2020)
Table 68. Asia Pacific AT1 Receptor Antagonists Revenue by Region (2015-2020) (US$ Million)
Table 69. Asia Pacific AT1 Receptor Antagonists Revenue Market Share by Region (2015-2020)
Table 70. Latin America AT1 Receptor Antagonists Sales by Country (2015-2020) (K Units)
Table 71. Latin America AT1 Receptor Antagonists Sales Market Share by Country (2015-2020)
Table 72. Latin Americaa AT1 Receptor Antagonists Revenue by Country (2015-2020) (US$ Million)
Table 73. Latin America AT1 Receptor Antagonists Revenue Market Share by Country (2015-2020)
Table 74. Middle East and Africa AT1 Receptor Antagonists Sales by Country (2015-2020) (K Units)
Table 75. Middle East and Africa AT1 Receptor Antagonists Sales Market Share by Country (2015-2020)
Table 76. Middle East and Africa AT1 Receptor Antagonists Revenue by Country (2015-2020) (US$ Million)
Table 77. Middle East and Africa AT1 Receptor Antagonists Revenue Market Share by Country (2015-2020)
Table 78. Pfizer Corporation Information
Table 79. Pfizer Description and Business Overview
Table 80. Pfizer AT1 Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 81. Pfizer AT1 Receptor Antagonists Product
Table 82. Pfizer Recent Development
Table 83. Novartis Corporation Information
Table 84. Novartis Description and Business Overview
Table 85. Novartis AT1 Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 86. Novartis Product
Table 87. Novartis Recent Development
Table 88. Merck Corporation Information
Table 89. Merck Description and Business Overview
Table 90. Merck AT1 Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 91. Merck Product
Table 92. Merck Recent Development
Table 93. Astra Zeneca Corporation Information
Table 94. Astra Zeneca Description and Business Overview
Table 95. Astra Zeneca AT1 Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 96. Astra Zeneca Product
Table 97. Astra Zeneca Recent Development
Table 98. Jhonson and Johnson Corporation Information
Table 99. Jhonson and Johnson Description and Business Overview
Table 100. Jhonson and Johnson AT1 Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 101. Jhonson and Johnson Product
Table 102. Jhonson and Johnson Recent Development
Table 103. Eli Lilly Corporation Information
Table 104. Eli Lilly Description and Business Overview
Table 105. Eli Lilly AT1 Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 106. Eli Lilly Product
Table 107. Eli Lilly Recent Development
Table 108. Sanofi Corporation Information
Table 109. Sanofi Description and Business Overview
Table 110. Sanofi AT1 Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 111. Sanofi Product
Table 112. Sanofi Recent Development
Table 113. Bristol-Myers Squibb Corporation Information
Table 114. Bristol-Myers Squibb Description and Business Overview
Table 115. Bristol-Myers Squibb AT1 Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 116. Bristol-Myers Squibb Product
Table 117. Bristol-Myers Squibb Recent Development
Table 118. Bayer Corporation Information
Table 119. Bayer Description and Business Overview
Table 120. Bayer AT1 Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 121. Bayer Product
Table 122. Bayer Recent Development
Table 123. GSK Corporation Information
Table 124. GSK Description and Business Overview
Table 125. GSK AT1 Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 126. GSK Product
Table 127. GSK Recent Development
Table 128. Teva Pharmaceutical Corporation Information
Table 129. Teva Pharmaceutical Description and Business Overview
Table 130. Teva Pharmaceutical AT1 Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 131. Teva Pharmaceutical Product
Table 132. Teva Pharmaceutical Recent Development
Table 133. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 134. Key Challenges
Table 135. Market Risks
Table 136. Main Points Interviewed from Key AT1 Receptor Antagonists Players
Table 137. AT1 Receptor Antagonists Customers List
Table 138. AT1 Receptor Antagonists Distributors List
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
List of Figures
Figure 1. AT1 Receptor Antagonists Product Picture
Figure 2. Global AT1 Receptor Antagonists Sales Market Share by Type in 2020 & 2026
Figure 3. Valsartan Product Picture
Figure 4. Telmisartan Product Picture
Figure 5. Losartan Product Picture
Figure 6. Irbesartan Product Picture
Figure 7. Azilsartan Product Picture
Figure 8. Olmesartan Product Picture
Figure 9. Global AT1 Receptor Antagonists Sales Market Share by Application in 2020 & 2026
Figure 10. Hypertension
Figure 11. Cardiovascular Diseases
Figure 12. Kidney Diseases
Figure 13. Other
Figure 14. AT1 Receptor Antagonists Report Years Considered
Figure 15. Global AT1 Receptor Antagonists Market Size 2015-2026 (US$ Million)
Figure 16. Global AT1 Receptor Antagonists Sales 2015-2026 (K Units)
Figure 17. Global AT1 Receptor Antagonists Market Size Market Share by Region: 2020 Versus 2026
Figure 18. Global AT1 Receptor Antagonists Sales Market Share by Region (2015-2020)
Figure 19. Global AT1 Receptor Antagonists Sales Market Share by Region in 2019
Figure 20. Global AT1 Receptor Antagonists Revenue Market Share by Region (2015-2020)
Figure 21. Global AT1 Receptor Antagonists Revenue Market Share by Region in 2019
Figure 22. Global AT1 Receptor Antagonists Sales Share by Manufacturer in 2019
Figure 23. The Top 10 and 5 Players Market Share by AT1 Receptor Antagonists Revenue in 2019
Figure 24. AT1 Receptor Antagonists Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 25. Global AT1 Receptor Antagonists Sales Market Share by Type (2015-2020)
Figure 26. Global AT1 Receptor Antagonists Sales Market Share by Type in 2019
Figure 27. Global AT1 Receptor Antagonists Revenue Market Share by Type (2015-2020)
Figure 28. Global AT1 Receptor Antagonists Revenue Market Share by Type in 2019
Figure 29. Global AT1 Receptor Antagonists Market Share by Price Range (2015-2020)
Figure 30. Global AT1 Receptor Antagonists Sales Market Share by Application (2015-2020)
Figure 31. Global AT1 Receptor Antagonists Sales Market Share by Application in 2019
Figure 32. Global AT1 Receptor Antagonists Revenue Market Share by Application (2015-2020)
Figure 33. Global AT1 Receptor Antagonists Revenue Market Share by Application in 2019
Figure 34. United States AT1 Receptor Antagonists Sales Growth Rate 2015-2026 (K Units)
Figure 35. United States AT1 Receptor Antagonists Revenue Growth Rate 2015-2026 (US$ Million)
Figure 36. United States AT1 Receptor Antagonists Market Share in Global Market 2015-2026
Figure 37. United States 5 and 10 Largest AT1 Receptor Antagonists Players Market Share by Revenue in AT1 Receptor Antagonists in 2019
Figure 38. United States AT1 Receptor Antagonists Revenue Share by Type (2015-2020)
Figure 39. United States AT1 Receptor Antagonists Revenue Growth Rate by Type in 2015 & 2019
Figure 40. United States AT1 Receptor Antagonists Revenue Share by Application (2015-2020)
Figure 41. United States AT1 Receptor Antagonists Revenue Growth Rate by Application in 2015 & 2019
Figure 42. North America AT1 Receptor Antagonists Sales Growth Rate 2015-2020 (K Units)
Figure 43. North America AT1 Receptor Antagonists Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. North America AT1 Receptor Antagonists Sales Market Share by Country in 2019
Figure 45. North America AT1 Receptor Antagonists Revenue Market Share by Country in 2019
Figure 46. U.S. AT1 Receptor Antagonists Sales Growth Rate (2015-2020) (K Units)
Figure 47. U.S. AT1 Receptor Antagonists Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Canada AT1 Receptor Antagonists Sales Growth Rate (2015-2020) (K Units)
Figure 49. Canada AT1 Receptor Antagonists Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Europe AT1 Receptor Antagonists Sales Growth Rate 2015-2020 (K Units)
Figure 51. Europe AT1 Receptor Antagonists Revenue Growth Rate 2015-2020 (US$ Million)
Figure 52. Europe AT1 Receptor Antagonists Sales Market Share by Country in 2019
Figure 53. Europe AT1 Receptor Antagonists Revenue Market Share by Country in 2019
Figure 54. Germany AT1 Receptor Antagonists Sales Growth Rate (2015-2020) (K Units)
Figure 55. Germany AT1 Receptor Antagonists Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. France AT1 Receptor Antagonists Sales Growth Rate (2015-2020) (K Units)
Figure 57. France AT1 Receptor Antagonists Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. U.K. AT1 Receptor Antagonists Sales Growth Rate (2015-2020) (K Units)
Figure 59. U.K. AT1 Receptor Antagonists Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Italy AT1 Receptor Antagonists Sales Growth Rate (2015-2020) (K Units)
Figure 61. Italy AT1 Receptor Antagonists Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Russia AT1 Receptor Antagonists Sales Growth Rate (2015-2020) (K Units)
Figure 63. Russia AT1 Receptor Antagonists Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Asia Pacific AT1 Receptor Antagonists Sales Growth Rate 2015-2020 (K Units)
Figure 65. Asia Pacific AT1 Receptor Antagonists Revenue Growth Rate 2015-2020 (US$ Million)
Figure 66. Asia Pacific AT1 Receptor Antagonists Sales Market Share by Region in 2019
Figure 67. Asia Pacific AT1 Receptor Antagonists Revenue Market Share by Region in 2019
Figure 68. China AT1 Receptor Antagonists Sales Growth Rate (2015-2020) (K Units)
Figure 69. China AT1 Receptor Antagonists Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Japan AT1 Receptor Antagonists Sales Growth Rate (2015-2020) (K Units)
Figure 71. Japan AT1 Receptor Antagonists Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. South Korea AT1 Receptor Antagonists Sales Growth Rate (2015-2020) (K Units)
Figure 73. South Korea AT1 Receptor Antagonists Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. India AT1 Receptor Antagonists Sales Growth Rate (2015-2020) (K Units)
Figure 75. India AT1 Receptor Antagonists Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Australia AT1 Receptor Antagonists Sales Growth Rate (2015-2020) (K Units)
Figure 77. Australia AT1 Receptor Antagonists Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Taiwan AT1 Receptor Antagonists Sales Growth Rate (2015-2020) (K Units)
Figure 79. Taiwan AT1 Receptor Antagonists Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Indonesia AT1 Receptor Antagonists Sales Growth Rate (2015-2020) (K Units)
Figure 81. Indonesia AT1 Receptor Antagonists Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Thailand AT1 Receptor Antagonists Sales Growth Rate (2015-2020) (K Units)
Figure 83. Thailand AT1 Receptor Antagonists Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Malaysia AT1 Receptor Antagonists Sales Growth Rate (2015-2020) (K Units)
Figure 85. Malaysia AT1 Receptor Antagonists Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Philippines AT1 Receptor Antagonists Sales Growth Rate (2015-2020) (K Units)
Figure 87. Philippines AT1 Receptor Antagonists Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Vietnam AT1 Receptor Antagonists Sales Growth Rate (2015-2020) (K Units)
Figure 89. Vietnam AT1 Receptor Antagonists Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Latin America AT1 Receptor Antagonists Sales Growth Rate 2015-2020 (K Units)
Figure 91. Latin America AT1 Receptor Antagonists Revenue Growth Rate 2015-2020 (US$ Million)
Figure 92. Latin America AT1 Receptor Antagonists Sales Market Share by Country in 2019
Figure 93. Latin America AT1 Receptor Antagonists Revenue Market Share by Country in 2019
Figure 94. Mexico AT1 Receptor Antagonists Sales Growth Rate (2015-2020) (K Units)
Figure 95. Mexico AT1 Receptor Antagonists Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Brazil AT1 Receptor Antagonists Sales Growth Rate (2015-2020) (K Units)
Figure 97. Brazil AT1 Receptor Antagonists Revenue Growth Rate (2015-2020) (US$ Million)
Figure 98. Argentina AT1 Receptor Antagonists Sales Growth Rate (2015-2020) (K Units)
Figure 99. Argentina AT1 Receptor Antagonists Revenue Growth Rate (2015-2020) (US$ Million)
Figure 100. Middle East and Africa AT1 Receptor Antagonists Sales Growth Rate 2015-2020 (K Units)
Figure 101. Middle East and Africa AT1 Receptor Antagonists Revenue Growth Rate 2015-2020 (US$ Million)
Figure 102. Middle East and Africa AT1 Receptor Antagonists Sales Market Share by Country in 2019
Figure 103. Middle East and Africa AT1 Receptor Antagonists Revenue Market Share by Country in 2019
Figure 104. Turkey AT1 Receptor Antagonists Sales Growth Rate (2015-2020) (K Units)
Figure 105. Turkey AT1 Receptor Antagonists Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Saudi Arabia AT1 Receptor Antagonists Sales Growth Rate (2015-2020) (K Units)
Figure 107. Saudi Arabia AT1 Receptor Antagonists Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. U.A.E AT1 Receptor Antagonists Sales Growth Rate (2015-2020) (K Units)
Figure 109. U.A.E AT1 Receptor Antagonists Revenue Growth Rate (2015-2020) (US$ Million)
Figure 110. Porter's Five Forces Analysis
Figure 111. AT1 Receptor Antagonists Value Chain
Figure 112. Channels of Distribution
Figure 113. Distributors Profiles
Figure 114. Bottom-up and Top-down Approaches for This Report
Figure 115. Data Triangulation
Figure 116. Key Executives Interviewed

Ask for discount before buying this report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Country :
  • Your Requirement
  • Security Code *
* denotes fields which must be completed

Buy This Report


Select License Type :

$ 3900
$ 5850

Do you wish to check sample of this report?

Have Query?


Research Assistance

For Enquiries, Call :

+1-800-998-4852US Toll Free

Email : sales@marketresearchhub.com

Back To Top